ADR Biomedical Holdings Inc. (TYO:3750)
Japan · Delayed Price · Currency is JPY 804.00
-1.00 (-0.12%)
Jul 16, 2026, 10:05 AM JST
ADR Biomedical Holdings Market Cap
ADR Biomedical Holdings has a market cap or net worth of 7.19 billion as of July 15, 2026. Its market cap has increased by 8.05% in one year.
Market Cap
7.19B
Enterprise Value
7.06B
Revenue
50.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
804.00
Market Cap Chart
Since June 28, 2006, ADR Biomedical Holdings's market cap has decreased from 8.22B to 7.19B, a decrease of -12.55%. That is a compound annual growth rate of -0.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 7.19B | -4.17% |
| Dec 30, 2025 | 7.50B | -2.89% |
| Dec 30, 2024 | 7.72B | -24.06% |
| Dec 29, 2023 | 10.17B | -6.18% |
| Dec 30, 2022 | 10.84B | -4.64% |
| Dec 30, 2021 | 11.37B | -10.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellSeed | 8.85B |
| Nano Holdings | 8.82B |
| K Pharma,Inc. | 8.43B |
| StemCell Institute | 7.89B |
| OncoTherapy Science | 7.67B |
| Carna Biosciences | 7.46B |
| Kidswell Bio | 7.44B |
| MEDINET | 7.00B |